Skip to main content
Luhua Wang, MD, Oncology, Houston, TX, University of Texas M.D. Anderson Cancer Center

LuhuaM.WangMD

Oncology Houston, TX

Physician

Dr. Wang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Wang's full profile

Already have an account?

Education & Training

  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1999 - 2002
  • Norwalk Hospital/Yale University
    Norwalk Hospital/Yale UniversityResidency, Internal Medicine, 1995 - 1998
  • University of Michigan Health System
    University of Michigan Health SystemInternship, Internal Medicine, 1994 - 1995
  • Shandong Medical University
    Shandong Medical UniversityClass of 1985

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • GA State Medical License
    GA State Medical License 2022 - 2025
  • TX State Medical License
    TX State Medical License 1998 - 2025
  • WA State Medical License
    WA State Medical License 2022 - 2025
  • AZ State Medical License
    AZ State Medical License 2022 - 2025
  • TN State Medical License
    TN State Medical License 2022 - 2024
  • MS State Medical License
    MS State Medical License 2022 - 2024
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Effect of Concurrent Chemoradiation with Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients with Non-Small Cell Lung Cancer with and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical Trial
    Effect of Concurrent Chemoradiation with Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients with Non-Small Cell Lung Cancer with and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical TrialDecember 2nd, 2019
  • FDA Approves Brukinsa
    FDA Approves BrukinsaNovember 14th, 2019

Hospital Affiliations